Endosteal-like extracellular matrix expression on melt electrospun written scaffolds by Muerza-Cascante, Maria Lourdes et al.
Accepted Manuscript
Endosteal-like extracellular matrix expression on melt electrospun written scaf-
folds
Maria Lourdes Muerza-Cascante, Ali Shokoohmand, Kiarash Khosrotehrani,
David Haylock, Paul D. Dalton, Dietmar W. Hutmacher, Daniela Loessner
PII: S1742-7061(16)30706-1
DOI: http://dx.doi.org/10.1016/j.actbio.2016.12.040
Reference: ACTBIO 4621
To appear in: Acta Biomaterialia
Received Date: 29 July 2016
Revised Date: 18 November 2016
Accepted Date: 16 December 2016
Please cite this article as: Muerza-Cascante, M.L., Shokoohmand, A., Khosrotehrani, K., Haylock, D., Dalton, P.D.,
Hutmacher, D.W., Loessner, D., Endosteal-like extracellular matrix expression on melt electrospun written
scaffolds, Acta Biomaterialia (2016), doi: http://dx.doi.org/10.1016/j.actbio.2016.12.040
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  
Endosteal-like extracellular matrix expression on melt electrospun written scaffolds 
 
Maria Lourdes Muerza-Cascante1, Ali Shokoohmand1, Kiarash Khosrotehrani2,3, David 
Haylock4,5, Paul D Dalton6, Dietmar W Hutmacher1,7,8 and Daniela Loessner1 
 
1. Institute of Health and Biomedical Innovation, Queensland University of Technology, 
Brisbane, QLD, Australia; 
2. The University of Queensland, UQ Centre for Clinical Research, Brisbane, QLD, Australia; 
3. The University of Queensland, UQ Diamantina Institute, Translational Research Institute, 
Brisbane, QLD, Australia; 
4. Commonwealth Scientific Industrial Research Organisation, Clayton, VIC, Australia; 
5. Australian Regenerative Medicine Institute, Monash University, Clayton, VIC, Australia; 
6. Department of Functional Materials in Medicine and Dentistry, University of Würzburg, 
Würzburg, Germany; 
7. George W Woodruff School of Mechanical Engineering, Georgia Institute of Technology, 
Atlanta, GA, USA; 
8. Institute for Advanced Study, Technical University of Munich, Garching, Germany. 
 
Corresponding author: Daniela Loessner 
Address: Institute of Health and Biomedical Innovation, Queensland University of 
Technology, 60 Musk Avenue, Kelvin Grove, QLD 4059, Brisbane, Australia 
Phone: +61-7-3138-6441 
Fax: +61-7-3138-6040 
Email: daniela.lossner@qut.edu.au 
 
Short title: Endosteal-like proteins on melt electrospun scaffolds 
 
Key words: melt electrospinning writing, ECM, bone, endosteum, haematopoietic stem cells 
 
Abstract: Tissue engineering technology platforms constitute a unique opportunity to 
integrate cells and extracellular matrix (ECM) proteins into scaffolds and matrices that 
mimic the natural microenvironments in vitro. The developments of tissue-engineered 3D 
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models that mimic the endosteal microenvironment enable researchers to discover the 
causes and improve treatments for blood and immune-related diseases. The aim of this 
study was to establish a physiologically relevant in vitro model using 3D printed scaffolds to 
assess the contribution of human cells to the formation of a construct that mimics human 
endosteum. Melt electrospun written scaffolds were used to compare the suitability of 
primary human osteoblasts (hOBs) and placenta-derived mesenchymal stem cells (plMSCs) 
in (non-)osteogenic conditions and different surface treatments. Using osteogenic 
conditions, hOBs secreted a dense ECM with enhanced deposition of endosteal proteins, 
such as fibronectin and vitronectin, and osteogenic marker proteins, such as osteopontin 
and alkaline phosphatase, compared to plMSCs. The expression patterns of these proteins 
were reproducibly identified in hOBs derived from three individual donors. Calcium 
phosphate-coated scaffolds induced the expression of osteocalcin by hOBs when 
maintained in osteogenic conditions. The tissue-engineered endosteal microenvironment 
supported the growth and migration of primary human haematopoietic stem cells (HSCs) 
when compared to HSCs maintained using tissue culture plastic. This 3D testing platform 
represents an endosteal bone-like platform and warrants future investigation for the 
maintenance and expansion of human HSCs. 
 
1. INTRODUCTION 
 Cellular niches are composed of multiple components with interactive roles and 
complex processes. The crosstalk between cells and their microenvironment can be 
investigated if these processes are broken-down and systematically analysed using a 
versatile technology platform that incorporates tissue-specific extracellular matrix (ECM) 
elements [1]. Tissue engineering has produced advanced tools that integrate cells into 
scaffolds and matrices that mimic specific features and the 3-dimensionality (3D) of their 
natural niche [2]. To design a tissue-specific technology platform, cells need to differentiate 
and secrete ECM that represents key characteristics of their surrounding microenvironment. 
Our group has demonstrated that cellular responses in such tissue-engineered models are 
more physiologically relevant than those obtained on 2-dimensional (2D) tissue culture 
surfaces [3-5]. 
The endosteum lines the inner wall of long bones that surround the bone marrow cavity [6]. 
This tissue has an important role in haematopoiesis, the physiological process that produces 
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all blood cells, and haematopoietic stem cells (HSCs) are located here [7, 8]. The cellular 
components of the endosteum, including osteoblasts, the bone-forming cells [9-11], and 
various ECM proteins, such as osteopontin (OPN; also secreted phosphoprotein 1, SSP1) [12, 
13], fibronectin (FN) [14], vitronectin (VN) [15] and neural cadherin (N-cad; also 
transmembrane protein cadherin-2, CHD2) [10], promote HSC growth, maintenance and 
differentiation. However, the exact contribution of these elements to HSC regulation is not 
well understood. The development of a physiologically relevant microenvironment based on 
tissue engineering strategies allows the incorporation of key extracellular factors of the 
endosteal HSC niche, thus provides an endosteal bone-like platform to improve the 
expansion of primitive HSCs in vitro. 
Traditionally, scaffolds have been used to support the formation of mineralised tissue, 
including bone, in vitro and in vivo. Different manufacturing technologies have been applied 
to produce scaffolds for bone tissue engineering [16-20]. Melt electrospinning writing is a 
3D printing technology which allows the design and fabrication of versatile and precise 3D 
architectures [21], with fibre dimensions down to the cell size [22], in a solvent-free process, 
representing an ideal platform for applications in bone tissue engineering [23]. Melt 
electrospun written scaffolds made of medical grade poly(ɛ-caprolactone) (PCL) have 
supported de novo formation of bone in vivo [24, 25]. Thus, melt electrospun PCL scaffolds 
represent a 3D testing platform to tailor characteristic components of the endosteal niche in 
a highly controlled fashion. 
The aim of this study was to establish a physiologically relevant in vitro 3D model to 
assess the species-specific contribution of cells to the formation of a human endosteum. 
The suitability of primary human osteoblasts (hOBs) and placenta-derived mesenchymal 
stem cells (plMSCs) to express key endosteal-like ECM proteins in response to different 
culture conditions and surface treatments of melt electrospun PCL scaffolds was 
characterised. In addition, 3D co-cultures of hOBs with primary human HSCs were 
performed to demonstrate the potential of this endosteal bone-like tissue for HSC 
expansion. 
 
2. MATERIALS AND METHODS 
 
2.1. Cell culture 
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Primary hOBs were isolated from 3 individual donors (2 males and 1 female) 
undergoing knee or hip replacement as described previously [26] and approved by the 
Human Research Ethics Committees (HREC/14/QPCH/186, QUT/1400001024). HOBs were 
grown in αMEM (Life Technologies, Mulgrave, VIC, Australia), supplemented with 10% fetal 
bovine serum (FBS) and 1% penicillin/streptomycin, and used at passages 2-7. Primary 
human plMSCs were isolated via enzymatic digestion as described previously [27] and 
approved by the Human Research Ethics Committee (HREC/09/QRBH/14). PlMSCs were 
grown in αMEM, containing 10% FBS and 1% penicillin/streptomycin, and used at passages 
2-4. CD34+ cells were obtained from cord blood from donors as approved by the Mercy 
Health Human Research Ethics Committee (R00/40) and pooled [12]. 
 
2.2. Preparation of melt electrospun written scaffolds, surface treatments and cell seeding 
Medical grade PCL (Corbion, Gorinchem, The Netherlands) was processed by melt 
electrospinning writing as described previously [28]. Briefly, PCL was heated to 100°C in a 
glass syringe. A syringe pump was used to extrude the polymer melt at 10 µl/h through a 
23G blunt-end spinneret that was separated 20 mm from a metallic collector. Subsequently, 
an electrical field of 11-12 KV was applied between the spinneret and the collector. 
Scaffolds (40 x 40 mm squares, with a 0-90° lay-down pattern, 10 stacked layers and 100 µm 
pore size) were produced by translating an automated flat collector in x and y direction. The 
collector was moved at 2,000 mm/min to match the velocity of the jet, which is necessary to 
attain the desired lay-down pattern. A laser-cutting device (Universal Laser Systems, 
Scottsdale, AZ, US) was used to cut the scaffolds in squares of 5 x 5 mm. 
Scaffolds were surface-treated with NaOH etching or calcium phosphate (CaP) coating 
to reduce the hydrophobicity of the surface and to enhance protein absorption and cell 
attachment. Briefly, NaOH etching was performed by soaking the scaffolds in 70% ethanol 
for 15 min before washed with distilled water and subjected to a 3M NaOH solution for 1 h 
at 37°C. Scaffolds were then washed with distilled water until pH 7 was reached. CaP 
coating of scaffolds was performed as described earlier [29]. After surface treatments, 
scaffolds were sterilised by immersion in 70% ethanol before air-dried and exposed to 
ultraviolet light for 20 min. 
Scaffolds were seeded with 5x104 hOBs or plMSCs. At day 7, osteogenic differentiation 
was induced for 4 weeks by adding 50 ng/mL ascorbate-2-phosphate (Sigma-Aldrich, Castle 
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Hill, NSW, Australia), 10 mM b-glycerophosphate (Sigma-Aldrich) and 0.1 mM 
dexamethasone (Sigma-Aldrich) to the culture medium [30]. Medium was changed every 3-
4 days. 
 
2.3. 3D co-culture of CD34+ cells with the endosteal microenvironment 
NaOH-etched scaffolds seeded with hOBs and maintained in osteogenic conditions 
were used for 3D co-cultures with CD34+ cells. Therefore, 2x105 CD34+ cells were cultured in 
1 mL StemSpan serum-free expansion medium II (Stem Cell Technologies, VIC, Australia) 
together with the hOB-seeded scaffolds. 3D co-cultures were carried out without cytokines 
and with a cytokine cocktail, consisting of stem cell factor, thrombopoietin, Fms-like 
tyrosine kinase 3 ligand and interleukin 6 at a final concentration of 10 ng/mL each. As 
control, CD34+ cells were cultured on tissue culture plates without or with the cytokine 
cocktail. After 5 days of 3D co-culture, CD34+ cells were collected in cold 0.5% bovine serum 
albumin (BSA) in phosphate-buffered saline (PBS) for counting via trypan blue staining and 
flow cytometry analysis. 
 
2.4. Immunofluorescence and confocal microscopy 
The deposition of ECM proteins secreted by hOBs and plMSCs onto scaffolds as well as 
CD34+ cell attachment were analysed by immunofluorescence. Samples were fixed with 4% 
paraformaldehyde, permeabilised in 0.2% Triton X-100 and blocked with 1% BSA/PBS. 
Primary antibodies (Table 1) were incubated in 1% BSA/PBS overnight at 4°C, followed by 
secondary goat anti-mouse/rabbit Alexa 488-conjugated antibodies (1:2,000; Life 
Technologies) in 1% BSA/PBS together with rhodamine415-conjugated phalloidin (1:250; 
Life Technologies) and DAPI (1:1,000; Life Technologies) for 45 min at room temperature. 
After washing with PBS, immunofluorescent staining was visualised with a Nikon A1R 
confocal microscope (Nikon, NSW, Australia), acquiring 30 μm z-stacks with 2 μm z-steps or 
20 μm z-stacks with 1 μm z-steps respectively, using 20x and 40x objectives. 
 
2.5. Scanning electron microscopy 
Scanning electron microscopy (SEM) was used to analyse the topography of hOBs and 
plMSCs grown on scaffolds. Samples were fixed with 3% glutaraldehyde, incubated in 0.1 M 
sodium cacodylate buffer for 30 min, immersed in 1% osmium tetroxide in cacodylate buffer 
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for 1 h and washed with ultra-pure water. Then, samples were dehydrated by a series of 
increasing ethanol concentrations (50-100%) and hexamethyldisilazane and finally mounted 
on SEM aluminium stubs and gold-coated in an EM-SCD005 sputter coater (Leica, NSW, 
Australia). Additionally, samples were carbon-coated for energy-dispersive X-ray 
spectroscopy (EDX). Images were taken with a Quanta 200 SEM (FEI, ACT, Australia) and a 
Sigma VP Field Emission SEM operating at 10 kV (Zeiss, NSW, Australia). 
 
2.6. DNA quantification 
The content of cellular DNA in hOBs and plMSCs grown on scaffolds was analysed by a 
PicoGreen assay (Life Technologies) . Briefly, samples were frozen for at least 48 hrs at -80°C 
before immersed in phosphate-buffered EDTA containing 0.5 mg/mL proteinase K (Life 
Technologies). Triplicate samples were mixed with PicoGreen assay reagent in black 96-well 
plates for 5 min at room temperature. Fluorescent signals were detected using a plate 
reader (excitation 485 nm, emission 520 nm). The DNA content of each sample was 
calculated using a DNA standard curve with concentrations between 10 ng/mL to 1 mg/mL. 
 
2.7. Western blot analysis 
The relative expression of ECM proteins produced by hOBs and plMSCs was 
investigated by Western blot analysis. Cell-seeded scaffolds were washed with PBS and 
whole cell extracts obtained by adding Radio Immuno-Precipitation Assay (RIPA) lysis buffer 
(150 mM NaCl, 1.0% IGEPAL® CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 
8.0; Sigma-Aldrich) containing phosphatase (1:10; Life Technologies) and protease (1:10; 
Roche Diagnostics, Indianapolis, IN, US) inhibitors. Cell lysates were centrifuged for 15 min 
at 14,000 x g and the supernatants collected to determine the protein concentrations using 
a Coomassie (Bradford) protein assay kit (Life Technologies). SDS-PAGE-resolved total 
protein samples (30 µg) were transferred onto a nitrocellulose membrane (Pall Corporation, 
Cheltenham, VIC, Australia) and probed with primary antibodies (Table 1), followed by 
secondary anti-mouse/rabbit HRP-conjugated antibodies (1:5,000; for VN 1:3,000; for OC 
1:1,000; Cell Signaling Technology, Danvers, MA, US) in 5% non-fat skim milk in Tris-buffered 
saline (10 mM Tris, 0.5 M NaCl; pH 7.6) containing 0.1% Tween-20 overnight at 4°C and 1 hr 
at room temperature respectively. Immunoreactivity was determined using enhanced 
chemiluminescence as per the manufacturer’s protocol (GE Healthcare, Melbourne, VIC, 
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Australia). Membranes were probed for equal loading using glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH; Table 1). The signal intensity of the protein bands was quantified 
using ImageJ (NIH, Bethesda, Maryland, US) and normalised to GAPDH. 
 
2.8 Alizarin Red S staining 
Samples were washed with PBS, fixed with 4% paraformaldehyde, rinsed with ultra-
pure water and incubated with 1% Alizarin Red S (Sigma-Aldrich) solution, pH 4.1 for 15 min 
at room temperature. After washing and air-drying overnight, images were taken with a 
Leica M125 stereo-microscope. 
 
2.9. Flow cytometry 
After cell counting, triplicate samples were pooled and stained with CD45-PE/Cy7 
(Table 1) for 30 min on ice. Samples were washed with cold 0.5% BSA/PBS and analysed 
with a BD FACSCanto flow cytometer (BD Biosciences, San Jose, CA, US). To determine 
viability of HSCs, propidium iodide (1:200) was used. 
 
2.10. Statistical analysis 
Data are presented as average and standard error of measurement of biological 
triplicate experiments. Statistical analysis was performed using One-way ANOVA and 
Tukey's test, with differences of P≤0.05 considered significantly different. 
 
3. RESULTS 
 
3.1. Engineering the endosteal niche 
Two different human cell types, hOBs and plMSCs, were grown on melt electrospun 
PCL scaffolds consisting of 10-stacked layers with 100-200 μm squared pores and fibre 
diameters of about 18 μm (Fig. 1). As non-treated PCL surfaces hinder cell attachment due 
to their hydrophobic surface, different surface treatments have been suggested to enhance 
cell attachment [31]. Previous studies from our group demonstrated that NaOH etching 
leads transformation of ester groups into carboxyl and hydroxyl groups. This active groups 
allow reproducible CaP coating of PCL scaffolds which results in enhanced cell attachment 
and improved osteoinductivity [30]. Therefore, scaffolds were NaOH-etched or CaP-coated 
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prior to cell seeding [29]. SEM analysis confirmed the uniform porous structure of the 
scaffolds and different surface morphology upon surface treatments (Fig. 1A-C). While non-
treated scaffolds had a smooth surface (Fig. 1A), NaOH-etched scaffolds had a rough surface 
(Fig. 1B), and CaP-coated scaffolds showed a characteristic micro- to nano-structured 
topography associated with this process (Fig. 1C). The endosteal niche was generated over 
35 days using 3 different scenarios with increased osteogenic stimulation: cells on NaOH-
etched scaffolds in non-osteogenic conditions (Fig. 1D), cells grown on NaOH-etched 
scaffolds (Fig. 1E) and CaP-coated scaffolds in osteogenic conditions (Fig. 1F). 
 
3.2. Attachment and growth of hOBs and plMSCs on scaffolds 
Prior to cell seeding onto scaffolds, immunophenotype profiling of hOBs and plMSCs 
was performed by flow cytometry, and the expression of endothelial (CD31, CD34), 
haematopoietic (CD45) and MSC (CD44, CD90, CD105 and CD146) markers assessed. Both 
cell types were negative for CD45, had negligible levels of CD31 as well as low CD34. They 
were both expectedly positive for CD44, CD90, CD105 and CD146 (Suppl. Fig.1). The 
attachment and growth of hOBs and plMSCs on non-coated and CaP-coated scaffolds was 
determined by SEM. Both cell types attached to both surface treatments and subsequently 
infiltrated the fully interconnected porous architecture with cells and ECM in non-
osteogenic and osteogenic conditions (Fig. 2A-F). While hOBs were homogenously 
distributed throughout the ordered 3D architecture, plMSCs did not completely fill the 
pores. To investigate cell migration into the scaffolds, the cross-section of cell-seeded 
scaffolds was also imaged by SEM (Fig. 2G-L). Cells appeared across the entire depth of the 
scaffolds in all conditions, with hOBs depositing a dense ECM in osteogenic conditions and 
upon CaP-coating (Fig. 2H-I). Next, the growth of both cell types was determined by 
measuring the DNA content. The growth of hOBs was significantly increased in osteogenic 
conditions and upon CaP coating compared to non-osteogenic conditions and plMSCs in all 
conditions tested (Fig. 3). Both SEM imaging and DNA analysis indicated that hOB growth 
and ECM deposition onto scaffolds were enhanced in osteogenic conditions compared to 
plMSCs. 
 
3.3. Characterisation of ECM proteins secreted by hOBs and plMSCs grown on scaffolds 
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To decipher the ECM production by hOBs and plMSCs grown on scaffolds, the 
expression and deposition of FN, VN, N-cad and collagen type-I (Col-I), representative of 
ECM proteins that regulate haematopoiesis at the endosteal site [10, 14, 15, 32], was 
determined by confocal microscopy and Western blot analysis. FN was abundant in all 
conditions tested and increased in hOBs compared to plMSCs (Fig. 4A). VN was also 
enhanced in hOBs compared to plMSCs (Fig. 4B). N-cad appeared in a punctuated staining 
pattern and was highly expressed in plMSCs compared to hOBs (Fig. 4C). Col-I was mostly 
intracellular in both hOBs and plMSCs in non-osteogenic conditions, while deposits were 
observed in osteogenic conditions (Suppl. Fig. 2). Next, the expression of the following 
osteogenic markers was determined: alkaline phosphatase (ALP), OPN and osteocalcin (OC; 
also bone gamma-carboxylglutamate acid-containing protein, BGLAP) [33]. ALP was highly 
expressed in the cytoplasm of hOBs in osteogenic conditions, and extracellularly upon CaP 
coating (Fig. 5A). OPN was also present in the cytoplasm, with a peri-nuclear staining 
pattern and increased expression in hOBs compared to plMSCs (Fig. 5B). OC was detected in 
all conditions tested, with a similar expression pattern as ALP in hOBs (Fig. 5C). 
To quantify the changes in protein expression detected via immunofluorescene, 
Western blot analysis and densitometry were performed (Fig. 6). Similar to the 
immunofluorescence results, FN was expressed at higher levels by hOBs compared to 
plMSCs. Likewise, VN expression was substantially higher in hOBs compared to plMSCs, in 
particular in non-osteogenic conditions. In contrast, N-cad expression was significantly 
higher in plMSCs compared to hOBs, independent of the conditions tested. ALP expression 
increased in both hOBs and plMSCs in osteogenic conditions, with hOBs producing 
significantly higher levels than plMSCs. Both hOBs and plMSCs expressed similar levels of 
OPN in response to all conditions tested. OC protein expression was only detectable upon 
CaP coating. These findings suggest that non-osteogenic and osteogenic conditions regulate 
the expression of specific endosteal and osteogenic markers in both hOBs and plMSCs. 
Altogether, hOBs produced higher levels of FN, VN and Col-I, while plMSCs expressed higher 
levels of N-cad. Osteogenic differentiation induced ALP and OC expression in combination 
with CaP coating. 
The mineralisation of the secreted ECM was analysed by Alizarin Red S staining (Suppl. 
Fig. 3A) and EDX analyses on surface particles (Suppl. Fig. 3B). Alizarin Red S-positive mineral 
deposits were only evident upon CaP-coating, with hOBs displaying a broad mineralisation 
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across the scaffold, and plMSCs showing a scattered mineralisation. Calcium (Ca) and 
phosphorus (P) were individually detected in surface particles deposited by both hOBs and 
plMSCs on CaP-coated scaffolds in osteogenic conditions, but were missing in the other 
conditions tested. 
 
3.4. Validation of ECM proteins secreted by hOBs derived from three different donors 
grown on scaffolds and tissue culture plastic 
As cell growth and secretion of key endosteal-like ECM proteins was enhanced in hOBs, we 
sought to determine the expression of these proteins in hOBs derived from three individual 
donors. The protein expression of hOBs grown on scaffolds (3D) was compared to those 
grown on tissue culture plastic (2D). Osteogenic conditions significantly increased the 
expression of FN, ALP, OPN and OC in 3D and 2D (Fig. 7A, D, E, F). Expression of FN was 
significantly higher in 3D compared to 2D independent of osteogenic conditions (Fig. 7A). 
Levels of VN were also increased in 3D compared to 2D, without reaching significance 
(P=0.059; Fig. 7B). The presence of N-cad was comparable in all conditions tested (Fig. 7C). 
The expression of ALP was similar in 3D and 2D, with a significant increase in cells grown in 
3D cultures in osteogenic conditions compared to non-osteogenic conditions (Fig. 7D). OPN 
was also significantly increased in 3D compared to 2D in both non-osteogenic and 
osteogenic conditions (Fig. 7E). In osteogenic conditions, OC was significantly upregulated in 
3D compared to 2D and upon CaP-coating (Fig. 7F). Strikingly, the endosteal and osteogenic 
expression patterns were reproducibly identified in hOBs derived from three individual 
donors (Fig. 7; Suppl. Fig. 4). These findings highlight the importance of 3D testing platforms 
for the development and production of physiologically relevant ECM microenvironments to 
study tissue-specific niches. 
 
3.5. Endosteal bone-like tissue supported CD34
+
/CD45
+
 cell growth and migration 
Based on these characterisation results, hOBs grown on NaOH-etched scaffolds in 
osteogenic conditions were used to investigate the suitability of this endosteal bone-like 
tissue to mimic the human haematopoietic niche. After 35 days of 3D culture, HSCs were 
introduced using cytokine-free and cytokine-containing conditions and collected after 5 
days of 3D co-culture for subsequent analyses. HSCs grown on tissue culture plastic served 
as 2D control. Using cytokine-free conditions, the number of CD45+ cells was increased in 3D 
  
 
 11
co-culture (1.49 x105 cells) compared to 2D (7.39 x104 cells), although the difference was 
not significant (Fig. 8A). The addition of cytokines to both cultures significantly increased the 
number of CD45+ cells. Using cytokine-containing conditions, the number of CD45+ cells was 
significantly higher in 3D co-culture (1.16 x106 cells) compared to 2D (7.8 x105 cells). The 
overall number of CD34+/CD38dim cells was similar between the 2D control (2.01 x104 cells) 
and 3D co-culture (7.27 x104 cells) without and with cytokines (2D: 5.11 x105 cells; 3D: 4.46 
x105 cells), without reaching significance (Fig. 8B). The addition of cytokines to both cultures 
significantly increased the number of CD34+/CD38dim cells. The number of CD34+/CD38+ cells 
was higher in 3D co-culture (9.57 x104 cells) compared to 2D (5.18 x104 cells) without 
cytokines (Fig. 8C). The presence of cytokines significantly increased the number of 
CD34+/CD38+ cells in 3D co-culture (4.76 x105 cells) compare to 2D (9.94 x104 cells). 
Migration of HSCs into the hOB-containing scaffolds was observed via confocal 
microscopy. CD45+ cells attached and migrated into the endosteal bone-like tissue (Fig. 8D). 
Some of the attached cells retained their CD34 expression (Fig. 8E). These findings indicate 
that the endosteal bone-like tissue incorporates additional cues that stimulate 
haematopoietic cell growth, migration and differentiation. 
 
4. DISCUSSION 
The endosteal site constitutes an important niche for HSC regulation. Cellular and ECM 
components in the endosteum play a critical role in HSCs proliferation, migration and 
differentiation [34]. However, the exact composition of the HSC niche and its molecular 
factors are not fully understood [35]. Novel experimental models that incorporate the 
complexity of the endosteal microenvironment in 3D testing platform are necessary to 
advance our understanding of the mechanisms related to haematopoiesis and to design 
improved protocols for the expansion of HSCs [36]. We sought to apply tissue engineering 
strategies to develop an endosteal niche by incorporation of key endosteal-like ECM 
proteins for the expansion of human HSCs. 
 
Tissue-engineered approaches to the HSC niche are frequently based on hydrogels [32, 37-
40]. However, the use of solid scaffolds with higher mechanical properties allows more 
complex approaches. An array of processing techniques is available to fabricate solid 3D 
architectures with tailored cellular and ECM components for in vitro 3D models. One of the 
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most common, solution electrospinning, produces scaffolds that support the proliferation 
and ALP activity of osteoblasts in vitro [41]. Their inherent small fibre diameters and 
arbitrary fibre deposition reduces the pore size, thus limits cell infiltration and possibly ECM 
production [42]. Jet-sprayed scaffolds also have small fibre diameters, but provide a high 
porosity that enhances cell infiltration, ECM production and osteogenic differentiation [43, 
44]. However, there is little control over fibre diameter and fibre deposition [48]. In 
contrast, melt spinning produces fibres with defined dimensions and controlled deposition, 
but large fibre diameters and low interconnectivity [45], which is essential for cell 
infiltration, thus, melt spun fibres require post-processing [19]. Fused deposition modelling 
(FDM) combines a controlled fibre deposition with motorised collectors to fabricate highly 
reproducible and interconnected fibrous scaffolds with large fibre diameters [20]. 
To overcome these limitations, melt electrospinning writing integrates electrospinning and 
FDM concepts. This 3D printing technique directly writes sub- and low-micron homogenous 
fibres with a controlled scaffold architectures, such as porosity, pore size and 
interconnectivity [46]. These properties facilitate cell functions and infiltration into the 
scaffold, which are directly linked to ECM production and deposition [23]. 
PCL has been extensively used for bone tissue engineering due to its inherent good 
mechanical properties, biocompatibility and low degradation rate [41, 43, 44]. Our group 
has already demonstrated that melt electrospun PCL scaffolds are suitable to engineer bone 
constructs to study species-specific mechanisms in vivo [24, 25]. However, the endosteal-
like ECM deposition by hOBs on melt electrospun PCL scaffolds has not been characterised 
[47, 48]. We sought to advance the species-specific application of these bone constructs as 
an in vitro HSC niche model. 
 
Osteoblasts and osteoprogenitor cells are key components of the endosteal niche [35] and 
obtained directly from bone tissue or upon osteogenic differentiation of MSCs [30]. MSCs 
are sourced from multiple tissues, including bone marrow [49] and placenta [50]. Bone 
marrow-derived MSCs (bmMSCs) have been used to develop in vitro models of the HSC 
niche [32, 38, 51]. However, plMSCs are more accessible than bmMSCs in terms of their 
isolation procedures and cell numbers per donor [52]. In this study, plMSCs displayed a 
CD44+/CD90+/CD105+/CD146+/CD31-/CD34-/CD45- phenotype that is similar as the 
phenotype generally observed in bmMSCs cells [53]. The osteogenic response of plMSCs 
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showed their osteogenic differentiation potential after 72 hrs [54]. Moreover, plMSCs grew 
faster and more robustly than bmMSCs, and had a similar capacity for osteogenic and 
chondrogenic differentiation after 3 weeks [52]. Importantly, plMSCs enhanced the HSC 
expansion in vitro [55, 56]. 
Thus, we investigated the ability of primary hOBs and plMSCs to produce an endosteal-like 
ECM when seeded onto melt electrospun PCL scaffolds. The fully interconnected 
architecture and pore size of the scaffolds allowed the migration of cells throughout the 
scaffold independent of the surface treatments. Cell growth was dependent on osteogenic 
conditions, with hOBs showing an enhanced growth and deposition of a dense ECM, which 
was reported earlier [57]. Strikingly, plMSC growth was not enhanced in osteogenic 
conditions, suggesting that plMSCs have a different osteogenic response compared to hOBs. 
 
Then, we characterised the endosteal-like ECM deposited by both cell types performing 
expression analyses of key proteins that are found at the endosteal site and play important 
roles in the HSC niche. FN is present in the endosteum and next to perivascular areas [32] 
and is linked to proliferation and migration of CD34+ cells [14]. VN is highly expressed in the 
bone marrow [15], promoting cell attachment and migration [58]. N-cad is a controversial 
component of the HSC niche; its expression and role in the HSC niche is still debated [10, 
59]. OPN is involved in bone homeostasis [60] and expressed by osteoblasts in the 
trabecular bone and endosteum [12]. Importantly, OPN regulates HSC proliferation and 
differentiation in vitro [12, 13]. FN and VN are linked to early osteogenic processes [33], 
while OPN indicates the presence of pre-osteoblastic cells [61]. ALP is an osteogenic marker 
expressed in the mature bone matrix, while OC appears later during the mineralisation of 
the bone matrix [33]. 
In this study, FN and VN were upregulated in NaOH-etched conditions, while CaP coating 
reduced their expression. OPN was enhanced in hOBs in non-osteogenic conditions. ALP was 
induced in osteogenic conditions, but CaP coating reduced its expression. OC was only 
expressed upon CaP coating of scaffolds. CaP coating accelerated the differentiation of hOBs 
and plMSCs to a later stage, which might explain the reduced expression of the investigated 
proteins in this condition. Generally, the protein expression was enhanced in hOBs 
compared to plMSCs, except for N-cad, which was not altered in osteogenic conditions and 
upon surface treatments. N-cad levels were only dependent on the cell type. The expression 
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of ALP by plMSCs in osteogenic conditions shows their ability to differentiate into the 
osteogenic lineage [30], which was also confirmed by the mineralisation and EDX analyses. 
The deposition of an endosteal-like ECM by hOBs was most effective when grown on NaOH-
etched scaffolds in osteogenic conditions. This is in agreement with other 3D culture 
approaches [32, 38, 51], which collectively demonstrate that levels of key endosteal factors, 
such as FN, VN, OPN and ALP, are enhanced in 3D compared to 2D controls. 
These findings suggest the physiological relevance of this endosteal bone-like tissue, which 
was also demonstrated by the consistent endosteal-like ECM expression of hOBs from three 
different donors. Nevertheless, plMSCs might be a favourable cell type to further investigate 
the role of N-cad in haematopoiesis. As the expression of endosteal proteins is likely related 
to the osteogenic differentiation stage, the use of a mixed cell population might ensure the 
presence of a mixed protein pool found in the endosteum. In fact, it has been suggested 
that the presence of both osteoblasts and osteoprogenitor cells compose the endosteal 
niche. There are possibly many other proteins present within this niche, which warrant 
future analysis [35]. For example, thrombospondin is involved in osteogenesis [63] and 
facilitates binding of haematopoietic progenitor cells [64]; laminin is implicated in the 
adhesion and migration of haematopoietic progenitor cells [65], although it is mainly 
located around bone marrow vessels [66]; and heparin sulphate is related to haemopoiesis 
[67] and promotes the proliferation of haematopoietic progenitor cells [68]. 
 
The suitability of this endosteal bone-like tissue as a 3D testing platform to study 
haematopoietic mechanisms was investigated upon 3D co-culture with primitive human 
HSCs. The 3D co-culture enhanced the number of CD45+ cells, in particular in the presence 
of cytokines compared to 2D controls. This in vitro 3D model represents additional, yet 
unknown, paracrine cues for HSC expansion. The migration of CD45+ cells into the endosteal 
bone-like tissue further suggests that some of the homing mechanisms were recapitulated 
in vitro. It was shown that osteoblasts play a role in HSC regulation [35] and maintenance of 
HSCs and progenitors [10, 11]. The endosteal site contributes to the self-renewal capacity of 
HSCs [8, 59, 69, 70]. However, other reports suggest that osteoblasts had no impact on 
primitive HSCs, but on committed B lymphocyte progenitors [71, 72]. Mineralised 
osteoblasts enhanced expansion of haematopoietic cells in 2D cultures, while myeloid [9] 
and lymphoid [73] differentiation was induced. The incorporation of bmMSCs in hydrogels 
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maintained primitive HSCs and induced differentiation of a sub-population [32, 37]. 
In this study, CD34+/CD38dim cell numbers were similar in 3D and 2D controls, suggesting 
that hOBs had no influence in retaining primitive HSCs. The cytokine cocktail was the only 
factor that enhanced the maintenance of less differentiated HSCs. HSC differentiation was 
induced in 3D as indicated by increased CD34+/CD38+ cell numbers. Collectively, hOBs and 
the endosteal-like ECM regulated differentiation rather than maintenance of HSCs in short-
term cultures, which is in line with the aforementioned reports. Future studies need to 
address the questions whether the endosteal bone-like tissue favours the dormant state of 
primitive HSCs, a cycling or quiescent sub-population or a specific lineage commitment, and 
whether direct cellular interactions between the scaffold and HSCs occur. 
 
5. CONCLUSIONS 
Scaffolds designed and fabricated via melt electrospinning writing sustain human cellular 
and key ECM components that are characteristic of the endosteal microenvironment. HOBs 
and plMSCs, grown on these scaffolds, developed a bone matrix with key ECM elements and 
variable stages of osteogenic differentiation. Matrix deposition and differentiation were 
enhanced by hOB-seeded scaffolds in osteogenic conditions. The endosteal bone-like tissue 
supported HSC proliferation and migration towards this bone matrix. This in vitro 3D model 
warrants future investigations for the expansion and differentiation of human HSCs. 
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FIGURE LEGENDS 
 
Figure 1. Experimental conditions to develop the in vitro 3D model. Melt electrospun 
written scaffolds were subjected to NaOH etching or CaP coating. Scanning electron 
microscopy images show scaffolds A) before surface treatments, with a smooth surface, 
after B) NaOH etching, with a rough surface, and C) CaP coating, with a micro- to nano-
structured topography. Primary human osteoblasts or placenta-derived mesenchymal stem 
cells were seeded onto surface-treated scaffolds for 35 days and grown in D) non-
osteogenic and E-F) osteogenic conditions. Scale bars: 100 μm, 20 μm (inserts). 
 
Figure 2: Cell attachment and growth on scaffolds. Scanning electron microscopy images of 
A-C) primary human oseoblasts (hOBs) and D-F) placenta-derived mesenchymal stem cells 
(plMSCs) indicate attachment and growth on scaffolds in non-osteogenic (A, D) and 
osteogenic (B, E) conditions and upon CaP coating (C, F) on day 35 of 3D culture. While hOBs 
were homogenously distributed throughout the scaffold (A-C), plMSCs did not completely 
fill the pores (D-F). Cross-section profiles of scaffolds seeded with G-I) hOBs and J-L) plMSCs 
across the entire depth of the scaffold revealed that hOBs secreted a dense ECM in 
osteogenic conditions and upon CaP coating (H, I) compared to non-osteogenic conditions 
(G) and plMSCs (J-L). Arrows point at cells, head arrows indicate ECM deposition and 
asterisks show fibres. Scale bars: 100 μm (A-F), 10 μm (inserts, A-F), 10 μm (G-L). 
 
Figure 3: DNA content of cells grown on scaffolds. The DNA content of primary human 
osteoblasts (hOBs) and placenta-derived mesenchymal stem cells (plMSCs) grown on 
scaffolds in non-osteogenic (Non-Ost) and osteogenic (Ost) conditions and with CaP coating 
(Ost+CaP) was determined on day 35 of 3D culture. In osteogenic conditions and upon CaP 
coating, the DNA content of hOBs was significantly enhanced compared to non-osteogenic 
conditions and plMSCs (**** - P≤0.0001). 
 
Figure 4: Expression of endosteal proteins by confocal microscopy. The expression of A) 
fibronectin (FN), B) vitronectin (VN) and C) N-cadherin (N-cad) by primary human 
osteoblasts (hOBs) and placenta-derived mesenchymal stem cells (plMSCs) in non-
osteogenic and osteogenic conditions and with CaP coating was detected on day 35 of 3D 
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culture. Proteins are depicted in green; cell nuclei in blue. FN and VN were abundant in 
hOBs, while N-cad was predominant in plMSCs. Scale bars: 50 μm, 200 μm (inserts). 
 
Figure 5: Expression of osteogenic proteins by confocal microscopy. The expression of A) 
alkaline phosphatase (ALP), B) osteopontin (OPN) and C) osteocalcin (OC) by primary human 
osteoblasts (hOBs) and placenta-derived mesenchymal stem cells (plMSCs) in non-
osteogenic and osteogenic conditions and with CaP coating was detected on day 35 of 3D 
culture. Proteins are depicted in green; cell nuclei in blue. ALP, OPN and OC were abundant 
in hOBs compared to plMSCs. Scale bars: 50 μm, 200 μm (inserts). 
 
Figure 6: Expression of endosteal and osteogenic proteins by Western blot analysis. A) The 
expression of fibronectin (FN), vitronectin (VN), N-cadherin (N-cad), alkaline phosphatase 
(ALP), osteopontin (OPN) and osteocalcin (OC) by primary human osteoblasts (hOBs) and 
placenta-derived mesenchymal stem cells (plMSCs) in non-osteogenic (Non-Ost) and 
osteogenic (Ost) conditions and with CaP coating (Ost+CaP) was detected on day 35 of 3D 
culture. B) Densitometry analysis showed that VN was upregulated in non-osteogenic 
conditions in hOBs. ALP was enhanced in osteogenic conditions in hOBs. In plMSCs, N-cad 
was increased and OC induced upon CaP-coating (n=2-4; mean ± SEM; * - P≤0.05, ** - 
P≤0.01, *** - P≤0.001). 
 
Figure 7: Expression of endosteal and osteogenic proteins in primary human osteoblasts 
(hOBs) derived from three different donors by Western blot analysis. Western blot and 
densitometry analyses of the expression of fibronectin (FN), vitronectin (VN), N-cadherin (N-
cad), alkaline phosphatase (ALP), osteopontin (OPN) and osteocalcin (OC) in hOBs in non-
osteogenic (Non-Ost) and osteogenic (Ost) conditions and with CaP coating (Ost+CaP) on 
day 35 of 3D culture. As 2D control, hOBs were grown on tissue culture plastic in non-
osteogenic (Non-Ost) and osteogenic (Ost) conditions. FN, ALP, OPN and OC were enhanced 
in 3D compared to 2D. ALP was induced upon 3D cultures in osteogenic conditions. OC was 
induced upon 3D cultures and CaP-coating (n=3; mean ± SEM; * - P≤0.05, ** - P≤0.01). 
 
Figure 8: CD34+ cell proliferation and differentiation in 3D co-culture with the endosteal 
bone-like tissue. A) Numbers of CD45+, B) CD34+/CD38dim and C) CD34+/CD38+ cells grown in 
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cytokine-free medium or with cytokines on tissue culture plastic (2D, 2D+Cyt) and in 3D co-
culture with hOB-seeded, NaOH-etched scaffolds using osteogenic conditions (3D Ost, 3D 
Ost+Cyt). A) Number of CD45+ cells was higher in 3D compared to 2D and significantly 
increased in the presence of cytokines. B) Number of CD34+/CD38dim cells was significantly 
increased in the presence of cytokines 3D and 2D. C) Number of CD34+/CD38+ cells was 
significantly increased in the presence of cytokines 3D and 2D (n=3; mean ± SEM; ** - 
P≤0.01, *** - P≤0.001, **** - P≤0.0001). D-E) Confocal microscopy showed that CD45+ and 
CD34+ cells (green) attached and migrated into hOB-seeded, NaOH-etched scaffolds using 
osteogenic conditions (red), as indicated by arrows; cell nuclei in blue. Scale bars: 100 μm. 
 
Supplementary Figure 1: Immunophenotype profile of primary human osteoblasts (hOBs) 
and placenta-derived mesenchymal stem cells (plMSCs). For both hOBs and plMSCs, a 
CD44+/CD90+/CD105+/CD146+/CD31-/CD34-/CD45- phenotype was detected. Red lines show 
isotype control, blue lines represent hOBs (top) and plMSC (bottom) levels. 
 
Supplementary Figure 2: Expression of Collagen type-I (Col-I). The expression of Col-I by 
primary human osteoblasts (hOBs) and placenta-derived mesenchymal stem cells (plMSCs) 
in non-osteogenic (Non-Ost) and osteogenic (Ost) conditions and with CaP coating 
(Ost+CaP) was detected on day 35 of 3D culture by confocal microscopy (protein in green; 
cell nuclei in blue). Scale bars: 50 μm, 200 μm (inserts). 
 
Supplementary Figure 3: Mineralisation of matrix secreted by primary human osteoblasts 
(hOBs) and placenta-derived mesenchymal stem cells (plMSCs). A) Alizarin Red S-positive 
mineral deposits were detected in osteogenic (Ost) conditions with CaP coating (Ost+CaP) 
on day 35 of 3D culture, with hOBs displaying a broader mineralisation compared to plMSCs. 
Scale bars: 5 mm, 200 μm (inserts). B) Scanning electron microscopy images (top) show 
surface particles deposited onto the matrix. The energy-dispersive X-ray spectra of these 
particles (bottom) indicate the presence of calcium (Ca) and phosphor (P). Asterisks mark 
surface particles. Scale bar: 10 μm. 
 
Supplementary Figure 4: Expression of endosteal and osteogenic proteins in primary 
human osteoblasts (hOBs) derived from three different donors by Western blot analysis. 
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The expression of fibronectin (FN), vitronectin (VN), N-cadherin (N-cad), alkaline 
phosphatase (ALP), osteopontin (OPN) and osteocalcin (OC) by hOBs in non-osteogenic 
(Non-Ost) and osteogenic (Ost) conditions and with CaP coating (Ost+CaP) was detected on 
day 35 of 3D culture. Cells grown on tissue culture plastic served as 2D control. FN and OPN 
were upregulated in 3D compared to 2D. Osteogenic conditions induced ALP expression. OC 
was induced upon CaP-coating. 3D culture data from donor 1 are depicted in figure 6A. 
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Table 1. Summary of antibodies used for immunofluorescence (IF), Western blot 
analysis (WB) and flow cytometry (FC). 
 
Name Clone 
Catalo
gue 
number 
Company 
Dilution 
I
F 
W
B 
F
C 
Fibronectin -- 
HFN 
7.1 
DSHB (Iowa City, 
IA, US) 
1
:200 
1:
500 
 
Vitronectin D-8 
sc-
74484 
Santa Cruz 
Biotechnology (Dallas, 
Texas, USA) 
1
:100 
1:
500 
 
N-cadherin -- 
ab122
21 
DSHB 
1
:200 
1:
400 
 
Collagen 
type-I 
I-8H5 
08631
70 
MP Biomedicals 
(NSW, Australia) 
1
:200 
1:
300 
 
Alkaline 
phosphatase 
F-4 
sc-
166261 
Santa Cruz 
Biotechnology 
1
:100 
1:
400 
 
Osteoponti
n 
-- 
MPIIIB
10(1) 
DSHB 
1
:200 
1:
200 
 
Osteocalcin OC4-30 
ab134
18 
Abcam (VIC, 
Australia) 
1
:100 
 
 
Osteocalcin EPR3690 
ab133
61 
Abcam 
 
1:
100 
 
Glyceralde
hyde-3-
phosphate 
dehydrogenase 
-- 
ab948
5 
Abcam  
1:
10,000 
 
CD45 
2B11 + 
PD7/26 
M0701 
Dako (NSW, 
Australia) 
1
:500 
 
 
PE/Cy7 
CD45 
HI30 
30401
6 
BioLegend (San 
Diego, CA, USA) 
1
:100 
 
1
:100 
      
 
CD31 WM59 
56165
3 
BD Biosciences, 
Franklin Lakes, USA 
  
1
:100 
CD34 581 
MCA1
578PE 
AbDSerotec, 
Raleigh, USA 
  
1
:100 
CD44 Bu52 
MCA2
504F 
BD Biosciences, 
Franklin Lakes, USA 
  
1
:100 
CD90 5E10 
32811
2 
BD Biosciences, 
Franklin Lakes, USA 
  
1
:100 
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CD105 266 
56083
9 
BD Biosciences, 
Franklin Lakes, USA 
  
1
:100 
CD146 OJ79c 
MCA2
141F 
AbD Serotec, 
Raleigh, USA 
  
1
:100 
 
  
  
  
  
  
  
  
  
  
  
*Graphical Abstract
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Statement of Significance. 
 
This work is motivated by the recent interest in melt electrospinning, a 3D printing 
technique used to produce porous scaffolds for biomedical applications in regenerative 
medicine. Our team has been among the pioneers in building a new class of melt 
electrospinning devices for scaffold-based tissue engineering. These scaffolds allow 
structural support for various cell types to invade and deposit their own extracellular matrix, 
mimicking a characteristic 3D microenvironment for experimental studies. 
We used melt electrospun written polycaprolactone scaffolds to develop an endosteal 
bone-like tissue that promotes the growth of hematopoietic stem cells. We combine tissue 
engineering concepts with materials science, cell biology and stem cell research to design a 
physiologically relevant niche that is of interest to the scientific community. 
 
